Company profile
Vaso Dynamics
Vaso Dynamics is a .......
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
RP04TM01 | Transaction MzQ0MjAwNDQ2MGFkaXF6a2N4 | Paper/PDF filed
Published 12 Nov 2024 07:00
CS01 | Transaction MzQzODYwNDEwMmFkaXF6a2N4
Published 07 Oct 2024 02:57
PSC07 | Transaction MzQzODYwMzA1NmFkaXF6a2N4
Published 07 Oct 2024 02:45
AP01 | Transaction MzQzMzQ5Mjc4M2FkaXF6a2N4
Published 28 Aug 2024 17:30
AP01 | Transaction MzQzMzQ5MzI2NGFkaXF6a2N4
Published 27 Aug 2024 16:42
AP01 | Transaction MzQzMzQ5MjMyMGFkaXF6a2N4
Published 27 Aug 2024 16:33
AP01 | Transaction MzQzMzQ5MTcwMWFkaXF6a2N4
Published 27 Aug 2024 16:28
TM01 | Transaction MzQyNzg4NTI2M2FkaXF6a2N4 | Paper/PDF filed
Published 06 Nov 2024 07:20
Company registered at Companies House
1 Jan 2025 to 31 Dec 2026
Cardiotoxicity is a major contributor for safety concerns in drug and vaccine development. In this project, we are building a Cardiac Organoid-on-Chip solution to address these problems. Currently, there are limited cardiac organoid related products on the market, whilst organoid technology has been favourably adopted in the biotech industry by pharmaceut...
